|1.||Nadella, M V P: 1 article (03/2004)|
|2.||Rosol, T J: 1 article (03/2004)|
|3.||Toribio, R E: 1 article (03/2004)|
|4.||LeRoy, B E: 1 article (03/2004)|
|5.||Leav, I: 1 article (03/2004)|
|6.||Kim, J S: 1 article (01/2001)|
|7.||Suh, E J: 1 article (01/2001)|
|8.||Kwon, S U: 1 article (01/2001)|
|9.||Yoon, S S: 1 article (01/2001)|
|10.||Chi, H S: 1 article (01/2001)|
01/01/2001 - "Arginine esterase seems to be safe and has significant fibrinolytic effects when administered in the patients with acute ischemic stroke. "
01/01/2001 - "Arginine esterase, a natural product from a snake venom, has been shown to reduce the serum fibrinogen level in human beings and may be useful in the treatment of ischemic stroke. "
01/01/2001 - "In the arginine-esterase treated group, D-dimer and FDP levels were significantly (p < 0.05) elevated, and fibrinogen level significantly (p < 0.05) decreased at 2-7 days after the onset of stroke compared to the heparin-treated group. "
|2.||Asthma (Bronchial Asthma)
01/01/1983 - "Arginine esterase activity of the plasma in different types of bronchial asthma."
06/01/1996 - "Diagnostic and prognostic values of the total arginine-esterase activity and the activity of leukocyte elastase (LE) in plasma of patients with allergic rhinitis (AR), atopic bronchial asthma (ABA) and atopic dermatitis (AD) were examined in this study. "
|3.||Anaphylaxis (Anaphylactic Shock)
01/01/1979 - "These studies describe the IgE-mediated release of a basophil kallikrein of anaphylaxis (BK-A) that has arginine esterase activity and is inhibited by plasma, DFP, and Trasylol. "
01/01/1979 - "We earlier reported the IgE-mediated release of a basophil kallikrein of anaphylaxis (BK-A) which, like plasma kallikrein, is an arginine esterase and cleaves human plasma kininogen generating immunoreactive kinin. "
|5.||Atopic Dermatitis (Atopic Eczema)
|1.||Snake Venoms (Snake Venom)
|2.||Fibrinogen (Factor I)
|4.||Immunoglobulin E (IgE)
|5.||Leukocyte Elastase (Neutrophil Elastase)